Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Osteoporosis

  Free Subscription


Articles published in Drugs Aging

Retrieve available abstracts of 13 articles:
HTML format



Single Articles


    February 2020
  1. BAHAT G, Ilhan B, Karan MA
    Comment on: "Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide".
    Drugs Aging. 2020 Feb 12. pii: 10.1007/s40266-020-00752.
    PubMed    


  2. RATERMAN HG, Lems WF
    Authors' Reply to Comment on "Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide".
    Drugs Aging. 2020 Feb 12. pii: 10.1007/s40266-020-00751.
    PubMed    


  3. LEE H, Jin Y, Roh M, Tsacogianis TN, et al
    Risk of Cataract Surgery and Age-Related Macular Degeneration After Initiation of Denosumab vs Zoledronic Acid for Osteoporosis: A Multi-Database Cohort Study.
    Drugs Aging. 2020 Feb 6. pii: 10.1007/s40266-020-00745.
    PubMed     Abstract available


    September 2019
  4. RATERMAN HG, Lems WF
    Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide.
    Drugs Aging. 2019 Sep 21. pii: 10.1007/s40266-019-00714.
    PubMed     Abstract available


    August 2019
  5. IWAMOTO J, Sato Y, Uzawa M, Takeda T, et al
    Retraction Note: Three-year Experience with Alendronate Treatment in Postmenopausal Osteoporotic Japanese Women with or without Renal Dysfunction: A Retrospective Study.
    Drugs Aging. 2019 Aug 16. pii: 10.1007/s40266-019-00702.
    PubMed     Abstract available


    May 2019
  6. SOLLING ASK, Harslof T, Langdahl B
    Current Status of Bone-Forming Therapies for the Management of Osteoporosis.
    Drugs Aging. 2019 May 8. pii: 10.1007/s40266-019-00675.
    PubMed     Abstract available


    April 2019
  7. HONVO G, Bannuru RR, Bruyere O, Rannou F, et al
    Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
    Drugs Aging. 2019;36.
    PubMed     Abstract available


    September 2018
  8. HUNNICUTT JN, Hume AL, Liu SH, Ulbricht CM, et al
    Commonly Initiated Opioids and Risk of Fracture Hospitalizations in United States Nursing Homes.
    Drugs Aging. 2018 Sep 6. pii: 10.1007/s40266-018-0583.
    PubMed     Abstract available


    March 2018
  9. DEEKS ED
    Author Correction to: Denosumab: A Review in Postmenopausal Osteoporosis.
    Drugs Aging. 2018 Mar 9. pii: 10.1007/s40266-018-0535.
    PubMed     Abstract available


    February 2018
  10. DEEKS ED
    Denosumab: A Review in Postmenopausal Osteoporosis.
    Drugs Aging. 2018 Feb 12. pii: 10.1007/s40266-018-0525.
    PubMed     Abstract available


    October 2017
  11. CATALANO A, Martino G, Morabito N, Scarcella C, et al
    Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach.
    Drugs Aging. 2017 Oct 4. doi: 10.1007/s40266-017-0492.
    PubMed     Abstract available


    April 2017
  12. IWAMOTO J, Sato Y, Takeda T, Matsumoto H, et al
    Retraction Note to: Efficacy of Antiresorptive Agents for Preventing Fractures in Japanese Patients with an Increased Fracture Risk: Review of the Literature.
    Drugs Aging. 2017 Apr 8. doi: 10.1007/s40266-017-0459.
    PubMed    


    May 2016
  13. VAN DE GLIND EM, Willems HC, Eslami S, Abu-Hanna A, et al
    Estimating the Time to Benefit for Preventive Drugs with the Statistical Process Control Method: An Example with Alendronate.
    Drugs Aging. 2016;33:347-53.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: